x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Help - - Sign up - Phone number 902 888 740
Search

Indexed in:

Index Medicus/Medline, Latindex, IBECS, IME, SCOPUS y MEDES

Metrics

  • SCImago Journal Rank (SJR):0,14
  • Source Normalized Impact per Paper (SNIP):0,141
doi: 10.1016/S1138-3593(00)73558-1
La menopausia en la medicina general/de familia
Felipe Chavida
Equipo de Atención Primaria de Brihuega. Guadalajara
This article is only available in PDF
Biblografía
1.
G.A. Greendale,N.P. Lee,E.R. Arriola
The menopause
Lancet, 353 (1999), pp. 571-580
2.
N.F. Woods,E.S. Mitchell
Anticipating menopause: observations from the Seattle Midlife Women's Health Study
Menopause, 6 (1999), pp. 167-173
3.
O.L. Svendsen,C. Hassager,C. Christiansen
Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women
Am J Med, 95 (1993), pp. 121-140
4.
M.S. LeBoff,L. Kohlmeier,S. Hurwitz,J. Franklin,J. Wright,J. Howacki
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
JAMA, 281 (1999), pp. 1505-1511
5.
S. McNagny
Prescribing hormone replacement therapy for menopausal women
Ann Intern Med, 131 (1999), pp. 605-616
6.
E. Barrett-Connor
Hormone replacement therapy
BMJ, 317 (1998), pp. 457-461
7.
Novak's gynecology (12.a ed.),
8.
Clinical gynecologic endocrinology and infertility (5.a ed.),
9.
L. Weinstein,C. Bewtra,J.C. Gallagher
Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient
Am J Obstet Gynecol, 162 (1990), pp. 1534-1539
10.
T.K. Chung,S.K. Yip,P. Lam,A.M. Chang,C.J. Haines
A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms
Maturitas, 25 (1996), pp. 115-123
11.
C.A. Staropoli,J.A. Flaws,T.I. Bush,A.W. Moulton
Predictors of menopausal hot flashes
J Womens Healthy, 7 (1998), pp. 1149-1155
12.
C. Egarter,M. Sator,P. Berghammer,J. Huber
Efficacy, tolerability, and rare side effects of tibolone treatment in postmenopausal women
Int J Gynaecol Obstet, 64 (1999), pp. 281-286
13.
K. Yaffe,G. Sawaya,I. Lieberburg,D. Grady
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia
JAMA, 279 (1998), pp. 688-695
14.
S. Waring,W.A. Rocca,R.C. Petersen,P.C. O'Brian,E.G. Tangalos,E. Kokmen
Postmenopausal estrogen replacement therapy and risk of Alzheimer disease: a population-based study
Neurology, 52 (1999), pp. 965-970
15.
E.E. Calle
Hormone replacement therapy and colorectal cancer: interpreting the evidence
Cancer Causes Control, 8 (1997), pp. 127-129
16.
The Eye-Disease Case-Control Study Group
Risk factors for neovascular age-related macular degeneration
Arch Ophthalmol, 110 (1992), pp. 1705-1708
17.
T.B. Pearlstein
Hormones and depression: what age the facts about premenstrual syndrome, menopause, and hormone replacement therapy?
Am J Obstet Gynecol, 173 (1995), pp. 646-653
18.
B.L. Harlow,D.W. Cramer,K.M. Annis
Association of medically treated depression an age at natural menopause
Am J Epidemiol, 141 (1995), pp. 1170-1179
19.
N.E. Avis,D. Brambilla,S.M. McKinlay,K. Vass
A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study
Ann Epidemiol, 4 (1994), pp. 214-220
20.
P.A. Kaufert,P. Gilbert,R. Tate
The Manitoba Project: a re-examination of the link between menopause and depression
Maturitas, 14 (1992), pp. 143-155
21.
L. Nicol-Smith
Causality, menopause, and depression: a critical review of the literature
BMJ, 313 (1996), pp. 1229-1232
22.
H. Joffe,L.S. Cohen,J. Hennen,K. Carlson
The perimenopause is a period of risk for depressive symptoms in middle-aged women [NR 13]
The American Psychiatric Association 152nd Annual Meeting, Washington, DC, (1999),
23.
C. Cooper,E.J. Atkinson,W.M. O'Fallon,L.J. Melton
Incidence of clinical diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989
J Bone Min Res, 7 (1992), pp. 221-227
24.
R.P. Heaney
Bone mass, bone loss, and osteoporosis prophylaxis
Ann Intern Med, 128 (1998), pp. 313-314
25.
S.L. Hui,C.W. Slemenda,C.C. Johnston Jr.
Age and bone mass as predictors of fracture in a prospective study
J Clin Invest, 81 (1988), pp. 1804-1809
26.
T.J. Wilkin
Changing perceptions in osteoporosis
BMJ, 318 (1999), pp. 862-864
27.
L. Sampietro-Colom,C. Almazán,A. Granados
Evaluación de la densitometría ósea
Agència d'Avaluació de Tecnologia Mèdica, mayo, (1993),
28.
D. Marshall,O. Johnell,H. Wedel
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
BMJ, 312 (1996), pp. 1254-1259
29.
Physician's Guide to prevention and treatment of osteoporosis
30.
N.F. Col,M.H. Eckman,R.H. Karas,S.G. Panker,R.J. Goldberg,E.M. Ross
Patient-specific decisions about hormone replacement therapy in postmenopausal women
JAMA, 277 (1997), pp. 1140-1147
31.
K. Grady,S.M. Rubin,D.B. Petitti,C.S. Fox,D. Black,B. Ettinger
Hormone therapy to prevent disease and prolong life in postmenopausal women
Ann Intern Med, 117 (1992), pp. 1016-1037
32.
B. Ettinger,D. Black,B. Mitlak,R.K. Knickerbocker,T. Nickelsen,H.K. Genant
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
JAMA, 282 (1999), pp. 637-645
33.
J. Studd,I. Arnala,P.M. Kicovic,D. Zamblera,H. Kroger,N. Holland
A randomized study of tibolone on bone mineral density in osteoporotic postmenopausal women with previous fractures
Obstet Gynecol, 92 (1998), pp. 574-579
34.
S.A. Beardsworth,C.E. Kearney,D.W. Purdy
Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial
Br J Obstet Gynaecol, 106 (1999), pp. 678-683
35.
S.L. Crawford,C.B. Johannes
The epidemiology of cardiovascular disease in postmenopausal women
J Clin Endocrinol Metab, 84 (1999), pp. 1803-1806
36.
G.A. Colditz,W.C. Willet,M.J. Stampfer,B. Rosner,F.E. Speizer,C.H. Hennekens
Menopause and the risk of coronary heart disease in women
N Engl J Med, 316 (1987), pp. 1105-1110
37.
T. Bush
The epidemiology of cardiovascular disease in post menopausal women
Ann N Y Acad Sci, 592 (1990), pp. 263-271
38.
H. Tunstall-Pedoe
Myth and paradox of coronary risk and the menopause
Lancet, 351 (1998), pp. 1425-1427
39.
L. Tomás Abadal
Riesgo cardiovascular en la menopausia: mito, paradoja o realidad. Importancia de las observaciones clínicas frente a la interpretación de los datos estadísticos
Rev Esp Cardiol, 52 (1999), pp. 463-466
40.
G.M. Rosano,G. Panina
Oestrogens and the heart
Therapie, 54 (1999), pp. 381-385
41.
G.M. Rosano,G. Panina
Cardiovascular pharmacology of hormone replacement therapy
Drugs Aging, 15 (1999), pp. 219-234
42.
The Writing Group for the PEPI Trial
Effects of estrogen or estrogen/ progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
JAMA, 273 (1995), pp. 199-208
43.
W.M. Van Baal,R.G. Smoleders,M.J. Van der Mooren,T. Teerlink,P. Kenemans
Hormone replacement therapy and plasma homocysteine levels
Obstet Gynecol, 94 (1999), pp. 485-491
44.
A. Tchernof,J. Calles-Escandon,C. Sites,E.T. Poehlman
Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy
Coron Arter Disk, 9 (1998), pp. 503-511
45.
S.R. Lindheim,D.M. Duffy,T. Kijima,M.A. Vijod,F.Z. Stanazyk,R.A. Lobo
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women
Fertil Steril, 62 (1994), pp. 1176-1180
46.
T. Raudaskoski,C. Tomas,T. Laatikainen
Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel
Acta Obstet Gynecol Scand, 78 (1999), pp. 540-545
47.
A.C. Duncan,H. Lyall,R.N. Roberts,J.R. Petrie,M.J. Perera,S. Monaghan
The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women
J Clin Endocrinol Metabol, 84 (1999), pp. 2402-2409
48.
C. Castelo-Branco,E.F. Casals,F. Figueras,A. Sanjuán,J.J. Vicente
Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AL and B
Menopause, 6 (1999), pp. 92-97
49.
K. Rödstrom,C. Bengtsson,L. Lissner,C. Björkelund
Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden
BMJ, 319 (1999), pp. 890-893
50.
S. Hulley,D. Grady,T. Bush,C. Furberg,D. Herrington,B. Riggs
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
JAMA, 280 (1998), pp. 605-613
51.
Collaborative Group on Hormonal Factors in Breast Cancer
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
Lancet, 350 (1997), pp. 1047-1059
52.
K.K. Steinberg,S.B. Thacker,S.J. Smith,D.F. Stroup,M.M. Zack,W.D. Flanders
A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer
JAMA, 265 (1991), pp. 1985-1990
53.
Europe Menopause Society
European consensus development conference on menopause
Hum Reprod, 11 (1996), pp. 975-979
54.
S.M. Gapstur,M. Morrow,T.A. Sellers
Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study
JAMA, 281 (1999), pp. 2091-2097
55.
S. Stallard,J.C. Litherland,C.M. Cordiner,H.M. Dobson,W.D. George,E.A. Mallon
Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study
BMJ, 320 (2000), pp. 348-349
56.
C. Schairer,J. Lubin,R. Troisi,M.H. Sturgeon,L. Brinton,R. Hoover
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
JAMA, 283 (2000),
57.
N.E. Col,S.G. Pauker,R. Goldberg,M.H. Eckman,E.M. Ross,J.B. Wong
Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women
Arch Intern Med, 159 (1999), pp. 1458-1466
Correspondencia: Dr. F. Chavida. Centro de Salud de Brihuega. Plaza del Jardinillo, 1. 19400 Brihuega. Guadalajara
Copyright © 2000. Elsevier España, S.L. y Sociedad Española de Medicina Rural y Generalista (SEMERGEN)